CardioBreak: MRI-Safe Afib Monitor; Missing Depression Meds; Hopping in HF

— Recent developments of interest in cardiovascular medicine

MedpageToday

Depression is undertreated in heart attack patients, with just 16% getting antidepressants compared with 42% of controls with depression, a study analysis showed.

The FDA granted premarket application approval to the BioMonitor 2 MRI-compatible cardiac monitor for patients with atrial fibrillation, syncope, bradycardia, and tachycardia.

But Class I recalls were issued for all models of the Fetch 2 aspiration catheters due to complaints of shaft breakage and for Guardian II hemostasis valves, used to prevent blood loss during catheterization procedures, due to a defect that could let in air and lead to embolism.

Cardiology and geriatrics societies united to say that systematic exclusion of people 75 and older from cardiovascular trials has left them unable to say much about evidence-based care, which is something they would like to see changed on both counts.

And in what may be one of the few randomized trials to use jumping ability as an endpoint in heart failure, researchers showed that Greek dancing made seniors jump higher and faster.

Immune cells attracted by inflammation in the brain after stroke help the brain heal, an animal study showed.

Meanwhile, yet another meta-analysis says that endovascular treatment works in ischemic stroke.

Warfarin patients' medication awareness is lowest on diet and drug interactions and when to seek medical care, a survey found.

PDE-4 inhibition, being studied for treatment of conditions ranging from asthma to psoriasis, might also help in treating metabolic disorders, a review suggested.

CardioBreak is a guide to what's new and interesting on the Web for cardiologists and other healthcare professionals with an interest in cardiovascular disease, powered by the MedPage Today community. Got a tip? Send it to us: c.phend@medpagetoday.com.